Insider Transactions in Q2 2023 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 04
2023
|
Jennifer Zachary EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
19,141
-35.27%
|
$2,239,497
$117.59 P/Share
|
|
May 04
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
436
-2.24%
|
$51,448
$118.22 P/Share
|
|
May 04
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
885
+4.35%
|
$104,430
$118.22 P/Share
|
|
May 04
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
447
-2.21%
|
$52,746
$118.22 P/Share
|
|
May 04
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
907
+4.3%
|
$107,026
$118.22 P/Share
|
|
May 04
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
279
-5.15%
|
$32,922
$118.22 P/Share
|
|
May 04
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
813
+13.04%
|
$95,934
$118.22 P/Share
|
|
May 04
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Open market or private sale
|
Direct |
15,875
-25.78%
|
$1,857,375
$117.53 P/Share
|
|
May 04
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
16,824
+11.26%
|
$1,514,160
$90.15 P/Share
|
|
May 04
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
326
-0.71%
|
$38,468
$118.22 P/Share
|
|
May 03
2023
|
Steven Mizell EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
53,400
-24.77%
|
$6,354,600
$119.01 P/Share
|
|
May 03
2023
|
Steven Mizell EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,000
+19.21%
|
$3,900,000
$75.52 P/Share
|
|
May 03
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-4.87%
|
$27,612
$117.89 P/Share
|
|
May 03
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
689
+12.45%
|
$80,613
$117.89 P/Share
|
|
May 03
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-0.61%
|
$32,292
$117.89 P/Share
|
|
May 03
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
803
+1.74%
|
$93,951
$117.89 P/Share
|
|
May 02
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Open market or private sale
|
Direct |
7,509
-40.44%
|
$871,044
$116.82 P/Share
|
|
May 02
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,035
+24.53%
|
$337,960
$56.04 P/Share
|
|
May 01
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
198
-1.56%
|
$22,770
$115.47 P/Share
|
|
May 01
2023
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
577
+4.34%
|
$66,355
$115.47 P/Share
|
|
May 01
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.71%
|
$36,685
$115.47 P/Share
|
|
May 01
2023
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
930
+2.03%
|
$106,950
$115.47 P/Share
|
|
May 01
2023
|
Dean Y Li Executive VP & President, MRL |
SELL
Payment of exercise price or tax liability
|
Direct |
524
-2.5%
|
$60,260
$115.47 P/Share
|
|
May 01
2023
|
Dean Y Li Executive VP & President, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,062
+4.81%
|
$122,130
$115.47 P/Share
|
|
May 01
2023
|
Caroline Litchfield EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-1.33%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Caroline Litchfield EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+2.63%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-2.16%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+4.21%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
221
-5.05%
|
$25,415
$115.47 P/Share
|
|
May 01
2023
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
643
+12.81%
|
$73,945
$115.47 P/Share
|
|
May 01
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-2.25%
|
$49,105
$115.47 P/Share
|
|
May 01
2023
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+4.38%
|
$99,590
$115.47 P/Share
|
|
May 01
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
75,436
-32.81%
|
$8,750,576
$116.03 P/Share
|
|
May 01
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
75,436
+24.7%
|
$4,224,416
$56.04 P/Share
|
|
Apr 28
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
66,163
-29.98%
|
$7,608,745
$115.0 P/Share
|
|
Apr 28
2023
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
66,163
+23.07%
|
$4,102,106
$62.07 P/Share
|
|
Apr 28
2023
|
Robert M Davis Chairman, CEO & President |
SELL
Open market or private sale
|
Direct |
143,329
-34.53%
|
$16,339,506
$114.93 P/Share
|
|
Apr 28
2023
|
Robert M Davis Chairman, CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
143,329
+25.66%
|
$8,026,424
$56.04 P/Share
|
|
Apr 26
2023
|
Joseph Romanelli President, Human Health Int?l |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$339
$113.68 P/Share
|
|
Apr 13
2023
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Open market or private sale
|
Direct |
134,055
-74.68%
|
$15,416,325
$115.06 P/Share
|
|
Apr 13
2023
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
134,055
+41.52%
|
$7,909,245
$59.06 P/Share
|